Healthcare -
Biotechnology - NASDAQ - US
$ 1.755
1.45 %
$ 267 M
Market Cap
-10.97
P/E
HRTX - STOCK-BASED COMPENSATION
Stock-based Compensation HRTX - Heron Therapeutics, Inc.
32.9 M
LAST VALUE
-16.26%
2 YEAR CAGR
-0.31%
5 YEAR CAGR
11.68%
10 YEAR CAGR